179 related articles for article (PubMed ID: 21133667)
1. Pharmaceutical interventions for mitigating an influenza pandemic: modeling the risks and health-economic impacts.
Postma MJ; Milne G; Nelson EA; Pyenson B; Basili M; Coker R; Oxford J; Garrison LP;
Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1431-9. PubMed ID: 21133667
[TBL] [Abstract][Full Text] [Related]
2. Mitigation of pandemic influenza: review of cost-effectiveness studies.
Lugnér AK; Postma MJ
Expert Rev Pharmacoecon Outcomes Res; 2009 Dec; 9(6):547-58. PubMed ID: 19941432
[TBL] [Abstract][Full Text] [Related]
3. Modeling pandemic preparedness scenarios: health economic implications of enhanced pandemic vaccine supply.
Medema JK; Zoellner YF; Ryan J; Palache AM
Virus Res; 2004 Jul; 103(1-2):9-15. PubMed ID: 15163482
[TBL] [Abstract][Full Text] [Related]
4. Modelling the health-economic impact of the next influenza pandemic in The Netherlands.
Hak E; Meijboom MJ; Buskens E
Vaccine; 2006 Nov; 24(44-46):6756-60. PubMed ID: 16797797
[TBL] [Abstract][Full Text] [Related]
5. Lessons from previous influenza pandemics and from the Mexican response to the current influenza pandemic.
Del Rio C; Hernandez-Avila M
Arch Med Res; 2009 Nov; 40(8):677-80. PubMed ID: 20304256
[TBL] [Abstract][Full Text] [Related]
6. Economics of stockpiling for an influenza pandemic.
Dhankhar P; Dasbach EJ; Elbasha EH
Lancet Infect Dis; 2009 Aug; 9(8):459-60. PubMed ID: 19628168
[No Abstract] [Full Text] [Related]
7. [Cost-effectiveness of prophylaxis and treatment of influenza].
Rychlik R; Heinen-Kammerer T; Rusche H; Piercy J; Scuffham P; Zöllner Y
Dtsch Med Wochenschr; 2003 Oct; 128(43):2267-70. PubMed ID: 14574642
[No Abstract] [Full Text] [Related]
8. Pandemic influenza: is there a corporate duty to prepare?
McMenamin JP
Food Drug Law J; 2009; 64(1):69-100. PubMed ID: 19998573
[TBL] [Abstract][Full Text] [Related]
9. The risk of seasonal and pandemic influenza: prospects for control.
Monto AS
Clin Infect Dis; 2009 Jan; 48 Suppl 1():S20-5. PubMed ID: 19067611
[TBL] [Abstract][Full Text] [Related]
10. The pandemic threat: are we prepared?
Lewis KK
Issue Brief (Mass Health Policy Forum); 2006 Jun; (29):1-14. PubMed ID: 16886304
[TBL] [Abstract][Full Text] [Related]
11. Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic.
Lugnér AK; Mylius SD; Wallinga J
Health Econ; 2010 May; 19(5):518-31. PubMed ID: 19382106
[TBL] [Abstract][Full Text] [Related]
12. Cost-benefit of stockpiling drugs for influenza pandemic.
Balicer RD; Huerta M; Davidovitch N; Grotto I
Emerg Infect Dis; 2005 Aug; 11(8):1280-2. PubMed ID: 16102319
[TBL] [Abstract][Full Text] [Related]
13. Anticipating crisis: towards a pandemic flu vaccination strategy through alignment of public health and industrial policy.
Daems R; Del Giudice G; Rappuoli R
Vaccine; 2005 Dec; 23(50):5732-42. PubMed ID: 16271423
[TBL] [Abstract][Full Text] [Related]
14. Pandemic influenza: overview of vaccines and antiviral drugs.
Cox MM
Yale J Biol Med; 2005 Oct; 78(5):321-8. PubMed ID: 17132338
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of stockpiling 23-valent pneumococcal polysaccharide vaccine to prevent secondary pneumococcal infections among a high-risk population in the United States during an influenza pandemic.
Dhankhar P; Grabenstein JD; O'Brien MA; Dasbach EJ
Clin Ther; 2010 Aug; 32(8):1501-16. PubMed ID: 20728763
[TBL] [Abstract][Full Text] [Related]
16. Preparing for the next influenza pandemic.
van Dalen PJ; Wijdenes C
Neth J Med; 2005 Oct; 63(9):337-8. PubMed ID: 16244379
[TBL] [Abstract][Full Text] [Related]
17. Investment in antiviral drugs: a real options approach.
Attema AE; Lugnér AK; Feenstra TL
Health Econ; 2010 Oct; 19(10):1240-54. PubMed ID: 19816857
[TBL] [Abstract][Full Text] [Related]
18. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
Rothberg MB; Rose DN
Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
[TBL] [Abstract][Full Text] [Related]
19. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
[TBL] [Abstract][Full Text] [Related]
20. [The evaluation of policies on 2009 influenza pandemic in Korea].
Choi WS; Kim WJ; Cheong HJ
J Prev Med Public Health; 2010 Mar; 43(2):105-8. PubMed ID: 20383042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
